Increased bioavailability of primaquine using poly(ethylene oxide) matrix extended-release tablets administered to beagle dogs

REFERENCES

• Baird JK, Fryauff DJ, Hoffman SL. (2003). Primaquine for prevention of malaria in travelers. Clinical Infections Diseases, 37, 1659–1667.
   PubMed Web of Science ®Google Scholar
• Baird JK, Reickmann K. (2003). Can primaquine therapy for vivax malaria be improved? Trends in Parasitology, 19, 115–120.
   PubMed Web of Science ®Google Scholar
• Baker JK, McChesney JD, Hufford CD, Clark AM. (1982). High-performance liquid chromatographic analysis of the metabolism of primaquine and the identification of a new mammalian metabolite. Journal of Chromatography, 230, 69–77.
   PubMed Web of Science ®Google Scholar
• Bertol CD, Cruz AP, Stulzer HK, Murakami FS, Silva MAS. (2010). Thermal decomposition kinetics and compatibility studies of primaquine under isothermal and non-isothermal conditions. Journal of Thermal Analysis and Calorimetry, 102, 187–192.
   Web of Science ®Google Scholar
• Colombo P, Sonvico F, Colombo G, Bettini R. (2009). Novel platforms for oral drug delivery. Pharmaceutical Research, 26, 601–611.
   PubMed Web of Science ®Google Scholar
• Cruz AP, Bertol CD, Stulzer HK, Murakami FS, Costella FT, Silva MAS. (2008a). Swelling, erosion, and release behavior of PEO/primaquine matrix tablets. Pharmaceutical Chemistry Journal, 42, 413–418.
   Google Scholar
• Cruz AP, Bertol CD, Murakami FS, Silva MAS. (2008b). Development and validation of RP-HPLC method for determination of primaquine in extended release tablets. Latin American Journal of Pharmacy, 27, 415–418.
   Web of Science ®Google Scholar
• Cuong BT, Binh VQ, Dai B, Duy DN, Lovell CM, Rieckmann KH, Edstein MD. (2006). Does gender, food or grapefruit juice alter the pharmacokinetics of primaquine in healthy subjects? British Journal of Clinical Pharmacology, 61, 682–689.
   PubMed Web of Science ®Google Scholar
• Dean RA, Ochieng W, Black J, Queener SF, Bartlett MS, Dumaual NG. (1994). Simultaneous determination of primaquine and carboxyprimaquine in plasma using high-performance liquid chromatography with electrochemical detection. Journal of Chromatography B: Biomedical Sciences and Applications, 655, 89–96.
   Google Scholar
• Dierling AM, Cui Z. (2005). Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy. International Journal of Pharmaceutics, 303, 143–152.
   PubMed Web of Science ®Google Scholar
• Dua VK, Kar PK, Sarin R, Sharma VP. (1996). High-performance liquid chromatographic determination of primaquine and carboxyprimaquine concentrations in plasma and blood cells in Plasmodium vivax malaria cases following chronic dosage with primaquina. Journal of Chromatography B, 675, 93–98.
   PubMedGoogle Scholar
• Endoh YS, Yoshimura H, Sasaki N, Ishihara Y, Sasaki H, Nakamura S, Inoue Y, Nishikawa M. (1992). High-performance liquid chromatographic determination of pamaquine, primaquine and carboxy primaquine in calf plasma using electrochemical detection. Journal of Chromatography, 579, 123–129.
   PubMed Web of Science ®Google Scholar
• FDA. (2001). Guidance for Industry: Bioanalytical Method Validation. Silver Spring, MD: US Department of Health and Human Services.
   Google Scholar
• Heller J, Barr J, Ng YS, Abdellauoi KS, Gurny R. (2002). Poly (ortho esters): synthesis, characterization, properties and uses. Advanced Drug Delivery Reviews, 54, 1015–1039.
   PubMed Web of Science ®Google Scholar
• Hoffman AS. (2008). The origins and evolution of ‘controlled’ drug delivery systems. Journal of Controlled Release, 132, 153–163.
   PubMed Web of Science ®Google Scholar
• Hofsteenge J, Capuano A, Altszuler R, Moore S. (1986). Carrier-linked primaquine in the chemotherapy of malaria. Journal of Medical Chemistry, 29, 1765–1769.
   PubMed Web of Science ®Google Scholar
• Jeans CW, Heard CM. (1999). A therapeutic dose of primaquine can be delivered across excised human skin from simple transdermal patches. International Journal of Pharmaceutics, 189, 1–6.
   PubMed Web of Science ®Google Scholar
• Johnston A, Woolard RC. (1983). Stripe: an interactive computer software program for the analysis of drug pharmacokinetcs. Journal of Pharmacological Methods, 9, 193–199.
   PubMedGoogle Scholar
• Kim YR, Kuh HJ, Kim MY, Kim YS, Chung WC, Kim S, Kang MW. (2004). Pharmacokinetics of primaquine and carboxyprimaquine in Korean patients with vivax malaria. Archives of Pharmacal Research, 27, 576–580.
   PubMed Web of Science ®Google Scholar
• Kojima H, Yoshihara K, Sawada T, Kondo H, Sako K. (2008). Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets. European Journal of Pharmaceutical Sciences, 70, 556–562.
   Google Scholar
• Krudsood S, Tangpukdee N, Wilairatana P, Phophak N, Baird JK, Brittenham GM, Looareesuwan S. (2008). High-dose primaquine regimens against relapse of Plasmodium vivax malaria. The American Journal of Tropical Medicine and Hygiene, 78, 736–740.
   PubMed Web of Science ®Google Scholar
• Lal J, Mehrotra N, Gupta RC. (2003). Analysis and pharmacokinetics of bulaquine and its major metabolite primaquine in rabbits using an LC-UV method — a pilot study. Journal of Pharmaceutical and Biomedical Analysis, 32, 141–150.
   PubMed Web of Science ®Google Scholar
• Lopes CM, Lobo JMS, Costa P. (2005). Formas farmacêuticas de liberação modificada: polímeros hidrofílicos. Brazilian Journal of Pharmaceutical Sciences, 41, 143–154.
   Google Scholar
• Maggi L, Bruni R, Conte U. (2000). High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms. International Journal of Pharmaceutics, 195, 229–238.
   PubMed Web of Science ®Google Scholar
• Mayorga P, Puisieux F, Couarraze G. (1996). Formulation study of a transdermal delivery system of primaquina. International Journal of Pharmaceutics, 132, 71–79.
   Web of Science ®Google Scholar
• Mayorga P, Deharo E, Puisieux F, Couarraze G. (1997). Interpretation and prediction of plasma levels of primaquine following transdermal delivery in Swiss mice. International Journal of Pharmaceutics, 155, 99–107.
   Web of Science ®Google Scholar
• Mihaly GW, Ward SA, Edwards G, Orme ML’E, Breckenridge AM. (1984). Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite. British Journal of Clinical Pharmacology, 17, 441–446.
   PubMed Web of Science ®Google Scholar
• Nasveld PE, Edstein MD, Reid M, Brennan L, Harris IE, Kitchener SJ, Leggat PA, Pickford P, Kerr C, Ohrt C, Prescott WTafenoquine Study Team. (2010). Randomized, double-blind study of the safety, tolerability, and efficacy of tafenoquine versus mefloquine for malaria prophylaxis in nonimmune subjects. Antimicrobial Agents and Chemotherapy, 54, 792–798.
   PubMed Web of Science ®Google Scholar
• Nitin M, Rajanikanth M, Lal J, Madhusudanan KP, Gupta RC. (2003). Liquid Chromatography — tandem mass spectrometric assay with a novel method of quantitation for the simultaneous determination of bulaquine and its metabolite, primaquine, in monkey plasma. Journal of Chromatography B, 793, 253–263.
   PubMed Web of Science ®Google Scholar
• Nora MV, Parkhurst GW, Thomas RW, Carson PE. (1984). High-performance liquid chromatographic-electrochemical assay method for primaquine in plasma and urine. Journal of Chromatography, 307, 451–456.
   PubMed Web of Science ®Google Scholar
• Parkhurst GW, Nora MV, Thomas RW, Carson PE. (1984). High-performance liquid chromatographic-ultraviolet determination of primaquine and its metabolites in human plasma and urine. Journal of Pharmaceutical Sciences, 73, 1329–1331.
   PubMed Web of Science ®Google Scholar
• Pathak SM, Kumar AR, Musmade P, Udupa N. (2008). A simple and rapid high performance liquid chromatographic method with fluorescence detection for the estimation of fexofenadine in rat plasma — application to preclinical pharmacokinetics. Talanta, 76, 338–346.
   PubMed Web of Science ®Google Scholar
• Pukrittayakamee S, Imwong M, Chotivanich K, Singhasivanon P, Day NPJ, White NJ. (2010). A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand. The American Journal of Tropical Medicine and Hygiene, 82, 542–547.
   PubMed Web of Science ®Google Scholar
• Rodrigues JM., Fessi H., Bories C., Puisieux F., Devissaguet J.-Ph. (1995). Primaquine-loaded poly(lactide) nanoparticles: physicochemical study and acute tolerance in mice. International Journal of Pharmaceutics, 126, 253–260.
   Web of Science ®Google Scholar
• Shanks GD, Oloo AJ, Aleman GM, Ohrt C, Klotz FW, Braitman D, Horton J, Brueckner R. (2001). A new primaquine analogue, tafenoquine (WR 238605), for prophylaxis against Plasmodium falciparum malaria. Clinical Infectious Diseases, 33, 1968–1974.
   PubMed Web of Science ®Google Scholar
• Singh KK, Vingkar SK. (2008). Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine. International Journal of Pharmaceutics, 347, 136–143.
   PubMed Web of Science ®Google Scholar
• Stensrud G, Sande SA, Kristensen S, Smistad G. (2000). Formulation and characterization of primaquine loaded liposomes prepared by a pH gradient using experimental design. International Journal of Pharmaceutics, 198, 213–228.
   PubMed Web of Science ®Google Scholar
• Sun Y, Peng Y, Chen Y, Shukla AJ. (2003). Application of artificial neural networks in the design of controlled release drug delivery systems. Advanced Drug Delivery Reviews, 55, 1201–1215.
   PubMed Web of Science ®Google Scholar
• Vale N, Moreira R, Gomes P. (2009). Primaquine revisited six decades after its discovery. European Journal of Medicinal Chemistry, 44, 937–953.
   PubMed Web of Science ®Google Scholar
• Walsh DS, Wilairatana P, Tang DB, Heppner D.G., Brewer T.G., Krudsood S., Silachamroon U., Phumratanaprapin W., Siriyanonda D., Looareesuwan S. (2004). Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse. Clinical Infectious Diseases, 39, 1095–1103.
   PubMed Web of Science ®Google Scholar
• Ward SA, Edwards G, Orme ML, Breckenridge AM. (1984). Determination of primaquine in biological fluids by reversed-phase high-performance liquid chromatography. Journal of Chromatography, 305, 239–243.
   PubMed Web of Science ®Google Scholar
• White NJ. (2008). The role of anti-malarial drugs in eliminating malaria. Malaria Journal, 7 (Suppl. 1), S8.
   PubMed Web of Science ®Google Scholar
• WHO. (2008). World Malaria Report 2008. Geneva: WHO.
   Google Scholar
• WHO. (2010). Guidelines for the Treatment of Malaria, 2nd Edn. Geneva: WHO.
   Google Scholar